References
- Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on US cancer burden. Cancer 2002;94:2766-92
- Marta GN, Del Nero LG, Marta GN, et al. Treatment priorities in oncology: do we want to live longer or better? Clinics 2014;69:509
- Siddiqui F, Liu AK, Watkins-Bruner D, et al. Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. J Clin Oncol 2014;32:2920-7
- Hayman J, Weeks J, Mauch P. Economic analyses in health care: an introduction to the methodogy with an emphasis on radiation therapy. Int J Radiat Oncol Biol Physics 1996;35:827-41
- International Atomic Energy Agency. DIRAC (DIrectory of RAdiotherapy Centres). http://www-naweb.iaea.org/nahu/dirac/query3.asp Accessed October 2014
- World Bank. Report No: 81924-YF; second Serbia health project (P129539). January 30, 2014. pp. 20.
- Jakovljević M, Ranković A, Rančić N, et al. Radiology services costs and utilization patterns estimates in Southeastern Europe—A retrospective analysis from Serbia. Value in Health Regional Issues 2013;2:218-25
- Jakovljevic MB. Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market. Farmeconomia. Health Econ Therap Pathways 2014;15:27-32
- Jakovljevic MB. Resource allocation strategies in Southeastern European health policy. Eur J Health Econ 2013;14:153-9
- Leopold C, Mantel-Teeuwisse AK, Vogler S, et al. Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Policy 2014:92(9) . In press
- Jakovljević M, Jovanović M, Lazić Z, et al. Current efforts and proposals to reduce healthcare costs in Serbia. SJECR 2011;12:161-3
- Jacobs VR, Thoedtmann J, Euler U, et al. Physician-based active cost management of oncological therapies reducing pharmaceutical costs by 83.4% in two years without leaving standard of care. Onkologie 2005;28:441-5
- Ranković A, Rančić N, Jovanović M, et al. Impact of imaging diagnostics on the budget: are we spending too much? Vojnosanitetski Pregled 2013;70:709-11
- Høilund-Carlsen PF, Gerke O, Vach W. Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis? Eur J Nucl Med Mol Imag 2014;41:1720-2
- Wilson GW, Jadlow JM. Competition, profit incentives, and technical efficiency in the provision of nuclear medicine services. Bell J Econ 1982;2:472-82
- Sleijfer S. “It’s the Economy, Stupid”: strategies for improved cost containment in cancer treatment. Clin Pharmacol Therap 2014;95:365-7
- Anand P, Kunnumakara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharmaceut Res 2008;25:2097-116
- Weissman JS, Stern R, Fielding SL, et al. Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med 1991;114:325-31
- Euro Care – Survival of cancer patients in Europe. http://www.eurocare.it/. Last accessed 25 August 2014
- WHO European Cancer Observatory. http://eco.iarc.fr/. Last accessed 15 September 2014
- Radovanović A, Dagović A, Jakovljević M. Economics of cancer related medical care: worldwide estimates and available domestic evidence. Arch Oncol 2011;19:59-63
- Chauvet B, Mazeron JJ, Mahe MA, et al. White paper of radiotherapy in France. Twelve objectives to improve one of the major cancer treatments-2013. Paris, France: Societe Francaise de Radiotherapie Oncologique-SFRO, Centre Antoine Beclere, Centre Universitaire des Saints Peres, 2013
- Jakovljevic M, Gutzwiller F, Schwenkglenks M, et al. Costs differentials among monoclonal antibodies-based first-line oncology treatment protocols for breast cancer, colorectal Carcinoma and non-Hodgkin's lymphoma. JBUON 2014; in press
- Liljegren G, Karlsson G, Bergh J, et al. The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial. Ann oncol 1997;8:757-63
- Rutigliano MJ, Lunsford LD, Kondziolka D, et al. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 1995;37:445-55
- Barbieri M, Weatherly HLA, Ara R, et al. What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. Appl Health Econ Health Policy 2014;12:497-510
- Blank JL, Hulst B. Optimal administrative scale for planning public services: a social cost model applied to Flemish hospital care. Int J Health Plan Manage 2014. DOI: 10.1002/hpm.2246
- Lievens Y, Grau C. Health economics in radiation oncology: introducing the ESTRO HERO project. Radiother Oncol 2012;103:109-12